LiverMultiScan as an alternative to liver biopsy to monitor autoimmune hepatitis in the National Health Service in England: an economic evaluation

BACKGROUND: Autoimmune hepatitis (AIH) is a rare chronic progressive liver disease, managed with corticosteroids and immunosuppressants and monitored using a combination of liver biochemistry and histology. Liver biopsy (gold standard) is invasive, costly and has risk of complications. Non-invasive...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajre, Mamta, Moawad, Mina, Shumbayawonda, Elizabeth, Carolan, Jane Elizabeth, Hart, Julie, Culver, Emma, Heneghan, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462097/
https://www.ncbi.nlm.nih.gov/pubmed/36691214
http://dx.doi.org/10.1136/bmjopen-2021-058999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462097/
https://www.ncbi.nlm.nih.gov/pubmed/36691214
http://dx.doi.org/10.1136/bmjopen-2021-058999

Ejemplares similares